Apyx Medical Corporation (APYX)
NASDAQ: APYX
· Real-Time Price · USD
2.15
0.03 (1.42%)
At close: Aug 15, 2025, 2:08 PM
Apyx Medical Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -17.32M | -20.13M | -23.56M | -28.51M | -28.41M | -22.88M | -18.83M | -15.29M | -16.41M | -20.84M | -23.28M | -19.22M | -17.66M | -16.26M | -15.2M | -14.72M | -14.22M | -14.86M |
Depreciation & Amortization | 556K | 580K | 599K | 609K | 651K | 646K | 692K | 742K | 772K | 868K | 890K | 917K | 935K | 901K | 903K | 899K | 888K | 900K |
Stock-Based Compensation | 2.81M | 3.34M | 4.01M | 4.09M | 4.44M | 4.88M | 5.11M | 5.84M | 6.18M | 6.41M | 6.7M | 6.4M | 5.89M | 5.54M | 5.09M | 4.75M | 4.63M | 4.36M |
Other Working Capital | -65K | -46K | -559K | 977K | 8.85M | 7.08M | 7.48M | 5.86M | -1.65M | -1.84M | -1.63M | 1.22M | 3.01M | 3.7M | 4.76M | 2.38M | -283K | -1.18M |
Other Non-Cash Items | 1.53M | 1.29M | 1.29M | 7.95M | 8.56M | 8.4M | 8.06M | 379K | 247K | 302K | 628K | 1M | 1.01M | 848K | 603K | 202K | 156K | 668K |
Deferred Income Tax | n/a | n/a | n/a | -1.96M | -1.75M | -4.07M | -4.07M | -2.11M | -2.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 3.11M | 2.51M | -394K | 2.25M | 9.09M | 5.07M | 5.54M | 2.87M | -5.1M | -4.38M | -5.22M | -4.63M | -3.96M | -3.94M | -1.84M | -2.81M | -2.14M | -1.77M |
Operating Cash Flow | -9.31M | -12.41M | -18.05M | -15.57M | -7.43M | -7.96M | -3.5M | -7.57M | -16.62M | -17.64M | -20.28M | -15.54M | -13.78M | -12.91M | -10.45M | -11.68M | -10.69M | -10.71M |
Capital Expenditures | -718K | -742K | -722K | -570K | -591K | -458K | -533K | -582K | -596K | -841K | -1.01M | -1.2M | -1.18M | -810K | -723K | -779K | -618K | -683K |
Cash Acquisitions | n/a | n/a | n/a | -7.41M | -7.27M | n/a | n/a | 7.41M | 7.27M | n/a | n/a | n/a | n/a | 195K | 195K | 195K | 195K | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | 7.41M | 7.27M | 14.53M | 14.53M | 7.12M | 7.27M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -718K | -742K | -722K | -570K | -591K | 6.81M | 6.73M | 6.68M | 6.67M | -841K | -1.01M | -1.2M | -1.18M | -810K | -723K | -779K | -618K | -683K |
Debt Repayment | -20K | -20K | -20K | 20.03M | 20.02M | 20.02M | 29.3M | 9.25M | 9.23M | 9.19M | -148K | -195K | -226K | -210K | -238K | -366K | -369K | -394K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 49K | 19K | -11K | n/a | 147K | 1.96M | 789K | 789K | 799K | -955K | 365K | 383K | 254K | 393K | 262K | 244K | 389K | 194K |
Financial Cash Flow | 6.8M | 6.78M | 6.75M | 22.07M | 22.24M | 22.3M | 30.41M | 8.31M | 8.28M | 8.23M | 217K | 188K | 28K | 183K | 24K | -71K | 71K | -149K |
Net Cash Flow | -3.38M | -6.27M | -11.91M | 5.88M | 14.2M | 21.03M | 33.46M | 7.3M | -1.58M | -9.98M | -20.68M | -16.07M | -14.61M | -13.3M | -11.04M | -12.64M | -11.49M | -11.84M |
Free Cash Flow | -10.03M | -13.15M | -18.77M | -16.14M | -8.02M | -8.41M | -4.03M | -8.15M | -17.22M | -18.48M | -21.29M | -16.74M | -14.96M | -13.72M | -11.17M | -12.46M | -11.31M | -11.39M |